Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Pharmacol Ther
; 143(1): 87-110, 2014 Jul.
Article
in En
| MEDLINE
| ID: mdl-24582968
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Lung Diseases
/
Mevalonic Acid
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Pharmacol Ther
Year:
2014
Document type:
Article
Affiliation country:
Canada
Country of publication:
United kingdom